About Company
- Legal Name: Samchundang Pharm. Co., Ltd
- Registered country: Republic of Korea
- Address: 71, Jeyakgongdan2-gil, Hyangnam-eup, Hwaseong-si, Gyeonggi-do
- Number of employees: 250 - 499
Description:
SamChunDang Pharm Co., Ltd. is a top Korean pharmaceutical company specializing in ophthalmic products, holding US and EU GMP certifications that position it as a leader in generic ophthalmic production. Its groundbreaking work includes developing a biosimilar for Eylea (Aflibercept), a macular degeneration treatment, earning industry recognition; SCD's vision extends beyond ophthalmology as it expands into non-ophthalmic fields including new drug delivery systems, oral GLP-1 and long-acting injections, aiming to revolutionize the global pharmaceutical industry.
Business Activities
Finished Dosage Forms
Manufacturer
Biopharmaceutical Products
Manufacturer
Innovator APIs
Manufacturer
Key Products/Services
- Finished Dosage Forms: Sodium hyaluronate 0.1%, 0.18%, 0.3% Eye Drops (multi/mono dose), Olopatadine 0.1%, 0.2% Eye Drops, Latanoprost preservative-free Eye Drops (mono dose), Moxista Eye drops(Multi/Single Dose), Oloten Eye Drops(Multi/Single dose), Olotenplus Eye Drops(Multi/Single Dose), Tolon Eye Drops(Multi/Single Dose), Sodium Hyaluronate 0.15% Eye Drops(Multi/Single Dose), IrisPlus Eye Drops (disposable)
- Biopharmaceutical Products: Eylea biosimilar vial & PFS
- Innovator APIs: Brimonidne/Timolol Eye Drops
Our Products & Services
Sell · Finished Dosage Forms
Certifications
FDA
GMP
ISO
Proofs
CPHI Milan 2026
10/2026 – 10/2026
CPHI Milan 2026
Ratings
(0)
(0)
(0)
(0)
(0)
Comments
Filters:
Sort by:
No comments available.
Leave your rating & comment